We only have this paper's title and publication details.
Read it at the sourceEC50 Values from TDCC assays with anti-DLL3 TriTAC in the T:A:C Configuration.
No takes yet. Share an insight, caveat, or question.
Molloy et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: